Fig. 1.
Study Cohort and Diagram. CMRI: cardiac magnetic resonance imaging; ALL: acute lymphocytic leukemia; AML: acute myeloid leukemia. Twenty patients (10–22 years) were prospectively enrolled between January 2013 and November 2014. Seventeen subjects completed visit 1 (30–60 mg/m2) and thirteen completed the remaining study visits (125–175 mg/m2, 200–250 mg/m2, 275–325 mg/m2, after max AC dose and 1 year after max AC dose)